BALAXI — Balaxi Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Balaxi Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	40	16.7	71.9	282	623
Net Total Accounts Receivable
Net Total Receivables	299	774	312	562	576
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	349	938	1,410	1,935	2,102
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.86	11.7	60.3	190	171
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	360	997	1,765	2,397	2,583
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82.2	347	633	531	542
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	82.3	347	633	568	570
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	277	650	1,132	1,829	2,014
Total Liabilities & Shareholders' Equity	360	997	1,765	2,397	2,583
Total Common Shares Outstanding